Pharmacokinetic and anti-inflammatory effects of sanguinarine solid lipid nanoparticles

Inflammation

Volumn 37, Issue 2, 2014, Pages 632-638

  Li, Weifeng ^a   Li, Huani ^a   Yao, Huan ^a   Mu, Qingli ^a   Zhao, Guilan ^a   Li, Yongmei ^a   Hu, Hua ^a   Niu, Xiaofeng ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

bioavailability; inflammation; inflammatory mediators; sanguinarine; solid lipid nanoparticles

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; SANGUINARINE; SODIUM CHLORIDE; SOLID LIPID NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG BIOAVAILABILITY; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; INTRAGASTRIC DRUG ADMINISTRATION; MALE; MAXIMUM PLASMA CONCENTRATION; MOUSE; MOUSE MODEL; NONHUMAN; PH; PLASMA CONCENTRATION-TIME CURVE; PROTEIN BLOOD LEVEL; RAT; SEPTIC SHOCK; SINGLE DRUG DOSE; SINUS VENOSUS; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BENZOPHENANTHRIDINES; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DISEASE MODELS, ANIMAL; DRUG CARRIERS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; ISOQUINOLINES; LIPIDS; LIPOPOLYSACCHARIDES; MALE; MICE; NANOPARTICLES; NITRIC OXIDE; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, SEPTIC; SOLUBILITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896400535     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9779-8     Document Type: Article

References (23)

1. Niu, X.; T. Fan, W. Li, W. Xing, and H. Huang. 2012. The anti-inflammatory effects of sanguinarine and its modulation of inflammatory mediators from peritoneal macrophages. Eur J Pharmacol 689: 262-269.
2. Mazzanti, G.; A. DiSotto, A. Franchitto, C.L. Mammola, P. Mariani, S. Mastrangelo, and A. Vitalone. 2009. Chelidonium majus is not hepatotoxic in Wistar rats, in a 4 weeks feeding experiment. J Ethnopharmacol 126: 518-524.
3. Mitscher, L.A.; S. Drake, S.R. Gollapudi, and S.K. Okwute. 1987. A modern look at folkloric use of anti-infective agents. Journal of natural products 50: 1025-1040.
4. Walterová, D.; J. Ulrichová, I. Valka, J. Vicar, C. Vavreckova, E. Taborska, and V. Simanek. 1994. Benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine: biological activities and dental care applications. Acta universitatis palackianae olomucensis Facultatis Medicae 139: 7-16.
5. Agarwal, S.; M.A. Reynolds, S. Pou, D.E. Peterson, J.A. Charon, and J.B. Suzuki. 1991. The effect of sanguinarine on human peripheral blood neutrophil viability and functions. Oral microbiology and immunology 6: 51-61.
6. Mehnert, W.; and K. Mäder. 2001. Solid lipid nanoparticles: production, characterization and applications. Advanced drug delivery reviews 47: 165-196.
7. Müller, R.H.; K. Mäder, and S. Gohla. 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. European journal of pharmaceutics and biopharmaceutics 50: 161-177.
8. Zur Mühlen, A.; C. Schwarz, and W. Mehnert. 1998. Solid lipid nanoparticles (SLN) for controlled drug delivery - drug release and release mechanism. European journal of pharmaceutics and biopharmaceutics 45: 149-155.
9. Joshi, M.D.; and R.H. Müller. 2009. Lipid nanoparticles for parenteral delivery of actives. European journal of pharmaceutics and biopharmaceutics 71: 161-172.
10. Shahgaldian, P.; E. Da Silva, A.W. Coleman, B. Rather, and M.J. Zaworotko. 2003. Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parameters. Int J Pharm 253: 23-38.
11. Song, X.; Y. Zhao, S. Hou, F. Xu, R. Zhao, J. He, and Q. Chen. 2008. Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency. European journal of pharmaceutics and biopharmaceutics 69: 445-453.
12. Zhang, X.; S. Lu, J. Han, S. Sun, L. Wang, and Y. Li. 2011. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with syringopicroside. Die Pharmazie-An International Journal of Pharmaceutical Sciences 66: 404-407.
13. Gao, S.; G. Fan, Z. Hong, X. Yin, S. Yang, and Y. Wu. 2006. HPLC determination of polydatin in rat biological matrices: application to pharmacokinetic studies. Journal of pharmaceutical and biomedical analysis 41: 240-245.
14. Riddick, T. 1968. Control of colloid stability through zeta potential: with a closing chapter on its relationship to cardiovascular disease. Wynnewood, PA: Zeta-Meter. Inc.
15. Suresh, G.; K. Manjunath, V. Venkateswarlu, and V. Satyanarayana. 2007. Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles. AAPS PharmSciTech 8: 162-170.
16. Wissing, S.; O. Kayser, and R. Müller. 2004. Solid lipid nanoparticles for parenteral drug delivery. Advanced drug delivery reviews 56: 1257-1272.
17. Li, W.; W. Xing, X. Niu, P. Zhou, and T. Fan. 2013. The pharmacokinetics of chelerythrine solution and chelerythrine liposomes after oral administration to rats. Planta medica 79: 654-660.
18. Heinzel, F.P.; R.M. Rerko, P. Ling, J. Hakimi, and D.S. Schoenhaut. 1994. Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infection and immunity 62: 4244-4249.
19. Suzuki, K.; K. Tateda, T. Matsumoto, F. Gondaira, S. Tsujimoto, and K. Yamaguchi. 2000. Effects of interaction between Escherichia coli verotoxin and lipopolysaccharide on cytokine induction and lethality in mice. Journal of medical microbiology 49: 905-910.
20. Leone, A.; S. Moncada, P. Vallance, A. Calver, and J. Collier. 1992. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. The Lancet 339: 572-575.
21. Nkeh, B.C.-A.; D. Njamen, J. Wandji, Z.T. Fomum, A. Dongmo, T.B. Nguelefack, and A. Kamanyi. 2003. Anti-inflammatory and analgesic effects of drypemolundein A, a sesquiterpene lactone from Drypetes molunduana. Pharmaceutical biology 41: 26-30.
22. Stoclet, J.C.; B. Muller, R. Andriantsitohaina, and A. Kleschyov. 1998. Overproduction of nitric oxide in pathophysiology of blood vessels. Biochemistry. Biokhimiya 63: 826.
23. Li, W.; T. Fan, Y. Zhang, X. Niu, and W. Xing. 2012. Effect of Chelerythrine against endotoxic shock in mice and its modulation of inflammatory mediators in peritoneal macrophages through the modulation of mitogen-activated protein kinase (MAPK) pathway. Inflammation 35: 1814-1824.